InsR sensitizers can bind to the InsR to activate the insulin pathway independent of insulin; thus, InsR sensitizers have the potential to alleviate insulin resistance and minimize the risk of hypoglycemia [19]. The gene discussed is INS; the disease is Insulin resistance.